About the benefits of immunotherapy for high-risk neuroblastoma
- PMID: 23295791
- DOI: 10.1200/JCO.2012.47.4080
About the benefits of immunotherapy for high-risk neuroblastoma
Comment in
-
Reply to L. Moreno et al.J Clin Oncol. 2013 Feb 10;31(5):650-1. doi: 10.1200/JCO.2012.47.4593. J Clin Oncol. 2013. PMID: 23520645 No abstract available.
Comment on
-
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.J Clin Oncol. 2012 Sep 10;30(26):3264-70. doi: 10.1200/JCO.2011.41.3807. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869886 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical